Research Article
BibTex RIS Cite
Year 2024, Volume: 5 Issue: 2, 34 - 37, 31.12.2024
https://doi.org/10.51539/biotech.1568132

Abstract

References

  • Altiok D, Alitok E,Bayraktar O,Tihminoglu F (2009) Stability of trnas-resveratrol incorporated in chitosan microspheres,14th National Biomedical Engineering Meeting.
  • Aytar M, Oryaşın E, Başbülbül G, Bozdoğan B (2019) Standardization study of the agar well diffusion method Bartın University International Journal of Natural and Applied Sciences 2(2):138-145.
  • Cui W, Wang Y, Zhang L, Liu F, Duan G, Chen S, Yang H (2024) Recent developments in the use of resveratrol against Staphylococcus aureus. Infections Med Int. 4(6):1-9.
  • Daş T, Daş G, Kapmaz M (2019) Evaluation of the antibacterial and antifungal effects of resveratrol on Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans In Vitro. Istanbul Gelisim University Journal of Health Sciences (8):739-750.
  • Faydoğlu E, Sürücüoğlu M (2013) Antimicrobial and antioxidant activities of medicinal and aromatic plants and their usage opportunities. Erzincan University Journal of Science and Technology 6(2): 233-265.
  • Karameşe M, Dicle Y (2022) The antibacterial and antibiofilm activities of resveratrol on Gram-positive and Gram-negative bacteria. Kafkas Journal of Medical Sciences 12(3): 201-206.
  • Kumar V, Yasmeen N, Pandey A, Ahmad Chaudhary A, Alawam A, Ahmad Rudayni H, Shaid M (2023) Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens frontiers in cellular and ınfection microbiology 13: 1293633.
  • Nakata R, Takahashi S, Inoue H (2012) Recent advances in the study on resveratrol. Biol Pharm Bull. 35(3):273-279.
  • Nøhr-Meldgaard K, Ovsepian A, Ingmer H, Vestergaard M (2018) Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus. Int J Antimicrob Agents 52(3): 390-396.
  • Otto M (2012) Molecular basis of Staphylococcus epidermidis infections In Seminars in immunopathology (Vol. 34, pp. 201-214). Springer-Verlag.
  • Patel K, Scott E, Brown V, Gescher A, Steward W, Brown K (2011) Clinical trials of resveratrol. Ann NY Acad Sci. 1215(1):161-169.
  • Paulo L, Ferrreira S, Gallardo E, Queiroz JA, Domingues F (2010) Antimicrobial activity and effects of resveratrol on human pathogenic bacteria. JMG 26:1533-1538
  • Kulkarni S, Cantó C (2015) The molecular targets of resveratrol. Biochim Biophys Acta. 1852(6):1114-1123.
  • Saran B, Karahan Z (2010) Overview of Antimicrobial Agents Turk Urol Sem 1,216-20.
  • Uysal M, Kaya B (2022) Resveratrol and its areas of effect Health Science-2022: Medical Research II, 155.
  • Vestergaad M, Ingmer H (2019)The Antibacterial and antifungal properties of resveratrol. Int J Antimicrob Agents 53 (6):716-723.

Determination of antibacterial activity of resveratrol on some pathogenic bacteria

Year 2024, Volume: 5 Issue: 2, 34 - 37, 31.12.2024
https://doi.org/10.51539/biotech.1568132

Abstract

This study aims to investigate the antibacterial effect of resveratrol, a natural polyphenol, on some pathogenic bacteria. Resveratrol is a compound found in plants such as red grapes and is known for its antioxidant, anti-inflammatory and antimicrobial properties. Due to these properties, it is considered as a potential agent in the prevention and treatment of bacterial infections. In this context, in this study, it was aimed to determine the antibacterial effects and effective dosage of resveratrol on Salmonella typhimurium, Staphylococcus epidermidis, Pseudomanas aeruginosa, Yersinia pseudotuberculosis, Proteus vulgaris, Enterococcus faecalis, Enterobacter cloaceae, Escherichia coli, and Listeria monocytogenes. Antibacterial activity studies were performed by agar well diffusion method. As a result of antibacterial activity studies, inhibition zones with a diameter of 14.0 ± 1.0 mm for S. epidermidis, 15.0 ± 0.5 mm for E. faecalis, 15.0 ± 0.5 mm for E. cloaceae and 16.0 ± 0.5 mm for L. monocytogenes were measured at 500 µg\mL dosage of resveratrol. However, resveratrol was found to have a bacteriostatic effect against S. typhimurium, P. aeruginosa, Y. pseudotuberculosis, P. vulgaris and E. coli. According to these results, it can be said that resveratrol may be effective against some pathogenic bacteria and may contribute to the development of new strategies for its use as an antibiotic adjuvant, although its use in terms of both food safety and public health is foreseen.

References

  • Altiok D, Alitok E,Bayraktar O,Tihminoglu F (2009) Stability of trnas-resveratrol incorporated in chitosan microspheres,14th National Biomedical Engineering Meeting.
  • Aytar M, Oryaşın E, Başbülbül G, Bozdoğan B (2019) Standardization study of the agar well diffusion method Bartın University International Journal of Natural and Applied Sciences 2(2):138-145.
  • Cui W, Wang Y, Zhang L, Liu F, Duan G, Chen S, Yang H (2024) Recent developments in the use of resveratrol against Staphylococcus aureus. Infections Med Int. 4(6):1-9.
  • Daş T, Daş G, Kapmaz M (2019) Evaluation of the antibacterial and antifungal effects of resveratrol on Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans In Vitro. Istanbul Gelisim University Journal of Health Sciences (8):739-750.
  • Faydoğlu E, Sürücüoğlu M (2013) Antimicrobial and antioxidant activities of medicinal and aromatic plants and their usage opportunities. Erzincan University Journal of Science and Technology 6(2): 233-265.
  • Karameşe M, Dicle Y (2022) The antibacterial and antibiofilm activities of resveratrol on Gram-positive and Gram-negative bacteria. Kafkas Journal of Medical Sciences 12(3): 201-206.
  • Kumar V, Yasmeen N, Pandey A, Ahmad Chaudhary A, Alawam A, Ahmad Rudayni H, Shaid M (2023) Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens frontiers in cellular and ınfection microbiology 13: 1293633.
  • Nakata R, Takahashi S, Inoue H (2012) Recent advances in the study on resveratrol. Biol Pharm Bull. 35(3):273-279.
  • Nøhr-Meldgaard K, Ovsepian A, Ingmer H, Vestergaard M (2018) Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus. Int J Antimicrob Agents 52(3): 390-396.
  • Otto M (2012) Molecular basis of Staphylococcus epidermidis infections In Seminars in immunopathology (Vol. 34, pp. 201-214). Springer-Verlag.
  • Patel K, Scott E, Brown V, Gescher A, Steward W, Brown K (2011) Clinical trials of resveratrol. Ann NY Acad Sci. 1215(1):161-169.
  • Paulo L, Ferrreira S, Gallardo E, Queiroz JA, Domingues F (2010) Antimicrobial activity and effects of resveratrol on human pathogenic bacteria. JMG 26:1533-1538
  • Kulkarni S, Cantó C (2015) The molecular targets of resveratrol. Biochim Biophys Acta. 1852(6):1114-1123.
  • Saran B, Karahan Z (2010) Overview of Antimicrobial Agents Turk Urol Sem 1,216-20.
  • Uysal M, Kaya B (2022) Resveratrol and its areas of effect Health Science-2022: Medical Research II, 155.
  • Vestergaad M, Ingmer H (2019)The Antibacterial and antifungal properties of resveratrol. Int J Antimicrob Agents 53 (6):716-723.
There are 16 citations in total.

Details

Primary Language English
Subjects Bacteriology, Microbiology (Other), Medical Bacteriology
Journal Section Research Articles
Authors

Nihal Mısır

Serpil Uğraş 0000-0002-1867-5781

Early Pub Date December 27, 2024
Publication Date December 31, 2024
Submission Date October 16, 2024
Acceptance Date November 20, 2024
Published in Issue Year 2024 Volume: 5 Issue: 2

Cite

APA Mısır, N., & Uğraş, S. (2024). Determination of antibacterial activity of resveratrol on some pathogenic bacteria. Bulletin of Biotechnology, 5(2), 34-37. https://doi.org/10.51539/biotech.1568132
AMA Mısır N, Uğraş S. Determination of antibacterial activity of resveratrol on some pathogenic bacteria. Bull. Biotechnol. December 2024;5(2):34-37. doi:10.51539/biotech.1568132
Chicago Mısır, Nihal, and Serpil Uğraş. “Determination of Antibacterial Activity of Resveratrol on Some Pathogenic Bacteria”. Bulletin of Biotechnology 5, no. 2 (December 2024): 34-37. https://doi.org/10.51539/biotech.1568132.
EndNote Mısır N, Uğraş S (December 1, 2024) Determination of antibacterial activity of resveratrol on some pathogenic bacteria. Bulletin of Biotechnology 5 2 34–37.
IEEE N. Mısır and S. Uğraş, “Determination of antibacterial activity of resveratrol on some pathogenic bacteria”, Bull. Biotechnol., vol. 5, no. 2, pp. 34–37, 2024, doi: 10.51539/biotech.1568132.
ISNAD Mısır, Nihal - Uğraş, Serpil. “Determination of Antibacterial Activity of Resveratrol on Some Pathogenic Bacteria”. Bulletin of Biotechnology 5/2 (December 2024), 34-37. https://doi.org/10.51539/biotech.1568132.
JAMA Mısır N, Uğraş S. Determination of antibacterial activity of resveratrol on some pathogenic bacteria. Bull. Biotechnol. 2024;5:34–37.
MLA Mısır, Nihal and Serpil Uğraş. “Determination of Antibacterial Activity of Resveratrol on Some Pathogenic Bacteria”. Bulletin of Biotechnology, vol. 5, no. 2, 2024, pp. 34-37, doi:10.51539/biotech.1568132.
Vancouver Mısır N, Uğraş S. Determination of antibacterial activity of resveratrol on some pathogenic bacteria. Bull. Biotechnol. 2024;5(2):34-7.